我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
0
0 进行中
药物批准
批准总数
监管机构
监管机构数
成立时间
N/A
暂无试验阶段数据
暂无试验数据
暂无批准数据
- Bassett Cancer Institute in Cooperstown becomes one of the first U.S. cancer centers to participate in an international clinical trial testing Alpha DaRT radiation therapy for inoperable pancreatic cancer. - The innovative treatment involves implanting radioactive seeds directly into tumors to deliver targeted alpha particle radiation from inside the cancer. - Only 30 patients will be enrolled across participating sites in the United States, Canada, and Israel before the trial closes to new participants. - The study represents a significant advancement in bringing cutting-edge cancer care to rural communities, with Bassett being likely the only rural site participating in this particular trial.
